http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111269875-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2506-45 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0676 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-071 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10 |
| filingDate | 2020-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-111269875-B |
| titleOfInvention | Method for directionally differentiating into islet cells by using autoimmune cells |
| abstract | The invention provides a method for directionally differentiating islet cells by utilizing autoimmune cells, which is characterized in that the method comprises the steps of obtaining the immune cells from peripheral blood of a patient, carrying out in-vitro dedifferentiation on the immune cells to induce pluripotent stem cells, and then directionally differentiating the cells to generate the islet cells. The method for culturing the islet cells selects the immune cells separated from the peripheral blood of a human body, induces and directionally differentiates the immune cells into the islet cells, and then transplants the islet cells into the same patient to reduce the immunological rejection of the patient. When Induced Pluripotent Stem Cells (iPSCs) are directionally induced and differentiated into islet cells, the purity of the finally induced islet cells is over 62.4% through DTZ staining identification after induced differentiation for 20-28 days. |
| priorityDate | 2020-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 213.